GW&K Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26K Buy
92
+2
+2% +$526 ﹤0.01% 738
2026
Q1
$24K Sell
90
-2
-2% -$542 ﹤0.01% 716
2025
Q4
$23K Sell
92
-20
-18% -$5.31K ﹤0.01% 715
2025
Q3
$32K Hold
112
﹤0.01% 626
2025
Q2
$29K Buy
112
+52
+87% +$12.7K ﹤0.01% 619
2025
Q1
$14K Hold
60
﹤0.01% 730
2024
Q4
$14K Buy
60
+2
+3% +$459 ﹤0.01% 698
2024
Q3
$13K Buy
58
+1
+2% +$220 ﹤0.01% 707
2024
Q2
$12K Buy
57
+15
+36% +$3.05K ﹤0.01% 683
2024
Q1
$9K Buy
42
+2
+5% +$441 ﹤0.01% 731
2023
Q4
$9K Buy
40
+1
+3% +$210 ﹤0.01% 709
2023
Q3
$8K Sell
39
-5
-11% -$1.05K ﹤0.01% 678
2023
Q2
$9K Buy
+44
New +$8.54K ﹤0.01% 641
2022
Q3
Sell
-9
Closed -$2K 641
2022
Q2
$2K Buy
9
+1
+13% +$213 ﹤0.01% 761
2022
Q1
$2K Buy
+8
New +$1.88K ﹤0.01% 710

Other funds holding LH

GW&K Investment Management's LH Position: Q2 2026 in Review

GW&K Investment Management increased its Labcorp (LH) stake by 2.2% in Q2 2026, buying an estimated $526 and bringing the position to 92 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #738.

GW&K Investment Management first reported a position in LH in Q1 2022 and has held it in 15 quarters since. The position peaked at $32K in Q3 2025. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • GW&K Investment Management held 92 shares of Labcorp worth $26K as of Q2 2026.
  • GW&K Investment Management bought 2 Labcorp shares in Q2 2026, an estimated $526.
  • Labcorp made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #738 holding.
  • GW&K Investment Management first reported a position in Labcorp in Q1 2022 and has held it in 15 quarters since.
  • GW&K Investment Management's Labcorp position peaked at $32K in Q3 2025.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.